Facts of the Case

  • The Arrangement: The corporate entity, Escorts Heart Institute and Research Centre Ltd. (the company), consistently purchased Keyman Insurance Policies on the lives of its key directors and employees, including its Chairman Mr. Rajan Nanda and Chief Cardiac Surgeon Dr. Naresh Trehan, paying high insurance premiums.
  • The Assignment: After paying the policy premiums for a certain duration, the company assigned the Keyman Insurance Policies over to the respective directors/employees upon receiving the calculated baseline surrender value from them.
  • Subsequent Payments: Following the valid assignment, the policies ceased to remain "Keyman Policies" from the insurer's viewpoint, and all subsequent periodic premium amounts till the final execution maturity date were deposited directly by the individual assignees.
  • The Revenue's Action: The Assessing Officer (AO) disallowed the premium deductions claimed by the company, asserting that the arrangement was a colourable transaction designed to pass untaxed corporate benefits to key personnel. Furthermore, the Revenue attempted to tax the difference between the actual premium paid and the surrender value as "salary/perquisite" under Section 17(3) in the directors' hands, and sought to tax the entire maturity value received upon realization.

Issues Involved

  1. Whether the premium amount deposited by a company on a Keyman Insurance Policy (after adjusting the corresponding surrender value received) qualifies as a valid, deductible business expenditure under Section 37(1) of the Income Tax Act.
  2. Whether the difference between the premium amount funded by the company and the lower surrender value paid by the employee during assignment can be legally categorized and taxed as "Salary" or "Profits in lieu of salary" under Section 17(3) of the Act.
  3. Whether the eventual maturity proceeds received by the individual directors/assignees after complete policy assignment remain taxable u/s 28(vi) or u/s 17(3), or if they are entirely exempt under Section 10(10D) of the Income Tax Act.

Petitioner’s (Revenue's) Arguments

  • Tax Avoidance Blueprint: The Revenue strongly argued that the iterative process of acquiring Keyman policies and quickly transferring them at lower surrender values constituted a "colourable device" and an illegitimate tax avoidance scheme.
  • Absence of Commercial Expediency: The Revenue contested that there was no real business rationale or commercial expediency for the company to absorb high premium commitments only to surrender all future claims and benefits to the directors shortly after.
  • Taxability as Perquisites/Salary u/s 17(3): It was asserted that the substantial difference between the high company premiums and nominal baseline surrender values paid by the directors represented an indirect compensation mechanism, which must be brought to tax as "profits u/s 17(3)".

Respondent’s (Assessee's) Arguments

  • Direct Compliance with Statutory Guidelines: The Assessee relied extensively on the central CBDT Circular No. 762 (dated 18-02-1998), which explicitly establishes that premiums deposited under a Keyman Insurance framework are fully deductible as operational business expenditures under Section 37(1).
  • Indemnification & Risk Management: The business objective was to insure the enterprise against unpredictable financial constraints arising from the loss of mission-critical human capital (such as an eminent cardiac surgeon or a strategic corporate chairman).
  • Legal Character Shift Post-Assignment: The respondents emphasized that post-assignment, the policies shed their character as "Keyman Policies" and converted into standard individual life insurance policies, making the maturity returns exempt from tax u/s 10(10D).

Court Order / Findings

  • Allowability of Premium Deductions: The Hon’ble Delhi High Court dismissed the Revenue's appeals, ruling that the premium paid by the company on Keyman Insurance is a legitimate business expenditure allowable under Section 37(1). The step protects the business's commercial stability from risks tied to key personnel.
  • No Taxable Salary/Perquisite u/s 17(3): The Court held that the difference between the premium paid and the surrender value does not equal a taxable perk or salary in the hands of the employee at the time of assignment. The assignment was performed at valid, documented surrender values recognized by the Life Insurance Corporation (LIC).
  • Tax Exemption on Maturity Proceeds: The Court affirmed that once a Keyman Policy is assigned to an individual, it converts into an ordinary life policy. Consequently, any maturity proceeds collected by the individual after the assignment are exempt from income tax under Section 10(10D).

Important Clarification

  • Status Transformation: A Keyman policy does not permanently retain its tax-disadvantaged status u/s 28(vi) or 10(10D) if it is legally assigned during its tenure. The character of the policy must be evaluated at the specific time of receipt of maturity proceeds. If it is an ordinary individual policy at maturity, Section 10(10D) statutory exemption applies seamlessly.
  • Consistency in Tax Administration: The Court also highlighted the necessity for consistent tax application, noting that the revenue cannot abruptly disregard its own binding circulars or previously accepted practices without substantial, distinguishing statutory changes.

Sections Involved

  • Section 37(1): General allowance for expenditures incurred wholly and exclusively for business purposes.
  • Section 10(10D): Statutory income-tax exemptions on sums received under life insurance policies.
  • Section 17(3): Provision regulating "profits in lieu of salary" and perquisites.
  • Section 28(vi): Taxability of sums received under a Keyman Insurance Policy including sums allocated by way of bonus.

Link to download the order -https://delhihighcourt.nic.in/app/case_number_pdf/2011:DHC:12002-DB/AKS16122011ITA4842009_150327.pdf

Disclaimer

This content is shared strictly for general information and knowledge purposes only. Readers should independently verify the information from reliable sources. It is not intended to provide legal, professional, or advisory guidance. The author and the organisation disclaim all liability arising from the use of this content. The material has been prepared with the assistance of AI tools.